Another recently completed phase 3 clinical trial called REDEFINE 2 , which included 1,207 adults with type 2 diabetes and overweight or obesity, found that after 68 weeks, CagriSema led to weight loss of almost 16% experts say the highest yet in the type 2 population, compared to other weight management drugs like tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) and semaglutide
Patients who have participated in NAD+ Therapy reported increased energy, mental clarity, focus and concentration, improved mood, memory, eyesight and hearing as well as decreased pain and withdrawal symptoms
FEK-060-14
Dysautonomia is a disorder resulting from dysfunction of the autonomic nervous system, which is a major component of the peripheral nervous system
Now, you can get B-12 shots at all SynergenX locations in Houston, Dallas, San Antonio, and the Chicago area